The 2009 program builds upon themes covered at our 2008 event, but with an expanded emphasis on case studies of drug development projects and strategies across therapeutic areas. It will also highlight areas of growing importance, particularly emerging technologies and research in the area of antibodies and other protein therapeutics.
Explore
Membership
